Display search results for ** instead (39 products)
19 Sep 2018  |  North America
Global Biologics Contract Development and Manufacturing Organization (CDMO) Market, Forecast to 2022
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global b...
28 Sep 2018  |  North America
New Surgical Paradigm to Deliver Value across Markets
This research service offers a strategic perspective of the customer, product, technology and competitors that are influencing the global market for surgical robotics. The report is split into three major sections, each focusing on industry overview, competitive landscape, and voice of stakeholder analysis. The report also includes sections for tec...
28 Sep 2018  |  North America
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
21 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, United States, Forecast to 2022
Despite Reaching Near Saturation, the Market will Grow at Healthy Rate Driven by High Procedural Volume Growth Coupled with Consistently High Replacements and Newer Installations
Endoscope reprocessing systems and workflow solutions was a $526.6 million market in the United States in 2017. It is expected to grow at healthy CAGR of 8.6% to reach $796.4 million in 2022. The market is segmented into two broad segments which are then divided into several sub-segments as mentioned below: • Endoscope reprocessing solutions ...
27 Jun 2018  |  North America
Endoscope Reprocessing Systems and Software Solutions Market Assessment, Australia, Forecast to 2022
The Market for Endoscope Reprocessing Solutions Would be Driven by Increasing Procedural Volumes, Coupled with Increased Demand for Newer Installations as Well as Replacements
The market for endoscope reprocessing systems and workflow solutions in Australia was worth A$61.1 million in 2017. It is expected to grow at a robust CAGR of 10.1% to reach a market size of A$98.7 million in 2022. The market is segmented into two broad segments, which are then divided into several sub-segments as mentioned below – • Endosco...
29 Jun 2018  |  North America
Using Cutting-edge Digital Technologies to Improve Patient Engagement and Adherence
Healthcare industry has undergone major transformation in the last decade with the incorporation of digital technologies. The changing technological as well as social trends, which focuses more on consumerism of healthcare which includes personalized interventions, making patients more accountable for their healthcare, disease awareness, is aimed t...
10 Jul 2018  |  North America
Cybersecurity, Artificial Intelligence, Virtual Care, Digital Therapeutics, and the Movements of Major Tech Companies Continue to Advance the Market
At the beginning of this decade, Frost & Sullivan invented the definition of Digital Health to include convergent market segments, such as healthcare information technology (HCIT), remote patient monitoring (RPM), mobile health (mHealth), and telemedicine. Over the last five years, these segments have become increasingly sophisticated as new techno...
25 Jul 2018  |  North America
Evaluating Growth Patterns and Opportunities Across X-ray Mammography Sets
Over the last 20 years, hospitals and imaging centers in developed economies have adopted X-ray mammography equipment to screen and diagnose breast cancer. This has led to significant reduction in mortality and prompted emerging countries to invest in population-based, organized screening. Significant investments in mammography technology have pave...
05 Oct 2018  |  North America
Companies are Vying for a Higher Market Position in the Early Cancer Screening Market
Liquid biopsy (CTCs and ctDNAs) is slowly gaining momentum in clinical care given its advantages over the traditional tissue-based gold standard methods. Short-term applications in cancer care range from risk assessment to cancer recurrence monitoring. Despite the proven advantages, there is still a significant number of barriers to adoption such a...
22 Oct 2018  |  North America
Digitalization and M&As to Transform the Current Competitive Structure of the Industry
The global life sciences instrumentation and research tools market is currently going through a transformation driven by ongoing market consolidation and technological innovation. Over the past five years, the industry has witnessed more than 50 mergers and acquisitions (M&A), which have resulted in a market consolidation at the top. Most of these ...